Deruxtecan

目录号: PL03589 纯度: ≥99%
Deruxtecan 是毒性药物和 linker 的偶联物。毒性药物是 DX-8951 (DXd) 衍生物,linker 是马来酰亚胺-GGFG 肽。Deruxtecan 可用于合成 DS-8201 和 U3-1402。
CAS No. :1599440-13-7
商品编号 规格 价格 会员价 是否有货 数量
PL03589-1mg 1mg ¥986.00 请登录
PL03589-5mg 5mg ¥2425.00 请登录
PL03589-10mg 10mg ¥3125.00 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
*注意事项:下单时请联系销售核实产品价格及货期,避免后续产生不便,感谢支持!
中文名称
Deruxtecan
英文名称
Deruxtecan
英文别名
Deruxtecan;5SEB972CO4;Deruxtecan [USAN];Mc-ggfg-dxd(1);N-(6-(2,5-Dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxohexyl)glycylglycyl-L-phenylalanyl-
Cas No.
1599440-13-7
分子式
C52H56FN9O13
分子量
1034.05
包装储存
-20°C, protect from light, stored under nitrogen In solvent : -80°C, 6 months; -20°C, 1 month (protect from light, stored under nitrogen)
详情描述

Deruxtecan 是毒性药物和 linker 的偶联物。毒性药物是 DX-8951 (DXd) 衍生物,linker 是马来酰亚胺-GGFG 肽。Deruxtecan 可用于合成 DS-8201 和 U3-1402。

产品详情
Deruxtecan 是毒性药物和 linker 的偶联物。毒性药物是 DX-8951 (DXd) 衍生物,linker 是马来酰亚胺-GGFG 肽。Deruxtecan 可用于合成 DS-8201 和 U3-1402。
生物活性
Deruxtecan is an ADC drug-linker conjugate composed of a derivative of DX-8951 (DXd) and a maleimide-GGFG peptide linker, used for synthesizing DS-8201 and U3-1402.
性状
Solid
IC50 & Target[1][2]
Camptothecins
体外研究(In Vitro)
Antibody-drug conjugates deliver anticancer agents selectively and efficiently to tumor tissue and have significant antitumor efficacy with a wide therapeutic window. has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
-20°C, protect from light, stored under nitrogen In solvent : -80°C, 6 months; -20°C, 1 month (protect from light, stored under nitrogen)
ClinicalTrial
参考文献
[1]. NOGUCHI, Shigeru, et al. METHOD FOR SELECTIVELY MANUFACTURING ANTIBODY-DRUG CONJUGATE. WO2017002776A1.
[2]. Ogitani Y, et al. Bystander killing effect of DS-8201a, a novel anti-human epidermal growth factor receptor 2 antibody-drug conjugate, in tumors with human epidermal growth factor receptor 2 heterogeneity. Cancer Sci. 2016 Jul;107(7):1039-46.
溶解度数据
In Vitro: DMSO : 35 mg/mL (33.85 mM; Need ultrasonic)配制储备液
搜索质检报告(COA)
[1]. NOGUCHI, Shigeru, et al. METHOD FOR SELECTIVELY MANUFACTURING ANTIBODY-DRUG CONJUGATE. WO2017002776A1.
[2]. Ogitani Y, et al. Bystander killing effect of DS-8201a, a novel anti-human epidermal growth factor receptor 2 antibody-drug conjugate, in tumors with human epidermal growth factor receptor 2 heterogeneity. Cancer Sci. 2016 Jul;107(7):1039-46.

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2